Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office.

BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today ↗

December 02, 2021

AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today ↗

Topics Intellectual Property

December 02, 2021

Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).

Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'...

40 Stocks Moving In Thursday's Mid-Day Session ↗

December 02, 2021

Via Benzinga

Topics Intellectual Property

Tuesday Markets Review ↗

November 30, 2021

The oil price did not fall as expected over the White House release of 50 mn bbls of oil.

Via Talk Markets

61 Biggest Movers From Yesterday ↗

November 23, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 200 Points; Niu Technologies Shares Slide ↗

November 22, 2021

Toward the end of trading Monday, the Dow traded up 0.59% to 35,811.07 while the NASDAQ fell 0.43% to 15,989.15. The S&P also rose, gaining 0.43% to 4,718.05. The U.S. has the...

Via Benzinga

Topics Stocks

Is An Aurinia Pharmaceuticals Buyout Coming? Why This Has Investors Doubting It ↗

November 22, 2021

Aurinia tanked Monday as an SEC filing had investors questioning buyout rumors.

Via Investor's Business Daily

Topics Regulatory Compliance

Financial Stocks: WFC, MS, C, BAC, JPM and GS Gain on Powell Fed Chairman’s Second Term ↗

November 22, 2021

Financial stocks are doing well on Monday thanks to an update from the U.S. Government concerning the next Federal Reserve chairman.

Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday.

Topics Economy

AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today ↗

November 22, 2021

Midway through trading Monday, the Dow traded up 0.65% to 35,832.70 while the NASDAQ rose 0.67% to 16,164.51. The S&P also rose, gaining 0.87% to 4,738.91. The U.S. has the...

Topics Regulatory Compliance

Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher ↗

November 22, 2021

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session ↗

November 22, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...

Via Benzinga

Here's Why Aurinia Pharmaceuticals Is Falling Today ↗

November 22, 2021

The company's recently filed unlimited shelf registration statement is making shareholders queasy.

Following the market opening Monday, the Dow traded up 0.77% to 35,876.58 while the NASDAQ rose 0.91% to 16,203.01. The S&P also rose, gaining 0.91% to 4,740.94. The U.S. has...

Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views ↗

November 22, 2021

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 22, 2021

Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!

Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...

20 Stocks Moving in Monday's Pre-Market Session ↗

November 22, 2021

Via Benzinga

Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday ↗

November 20, 2021

A $250 mixed shelf offering isn't sitting well with the biotech's shareholders.

Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference

November 10, 2021

Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move? ↗

November 06, 2021

It could be.

Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:

What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals ↗

November 04, 2021

Via Benzinga

Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

AUPH earnings call for the period ending September 30, 2021.

The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on.

Topics Earnings

Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals ↗

November 03, 2021

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the...

Aurinia Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2021

Via Benzinga

Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates

November 03, 2021

Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis

November 01, 2021

Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.

No Negative Reaction ↗

October 28, 2021

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 ↗

October 28, 2021

Upgrades For Boot Barn Holdings Inc (NYSE:

Via Benzinga

Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021

October 27, 2021